|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product | |||||
| Service | |||||
| License, Royalty and Other | |||||
| License Royalty and Other | |||||
| Total revenues | |||||
| Operating expenses | |||||
| Cost of revenues | |||||
| Product | |||||
| Service | |||||
| License, Royalty and Other | |||||
| License Royalty and Other | |||||
| Total cost of revenues | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Change in fair value of contingent consideration liability | |||||
| Goodwill impairment | |||||
| IPR&D impairment | |||||
| Amortization of acquired intangible assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of warrant liabilities | |||||
| Other income (expense), net | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of debt | |||||
| Loss on debt extinguishment | |||||
| Other expense, net | |||||
| Amortization of licensing obligation premium | |||||
| Loss on issuance of convertible notes with warrants | |||||
| Impairment of preferred stock investment | |||||
| Compliance fees and other expense, net | |||||
| Total other expense | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Change in fair value of debt due to change in credit risk, net of tax | |||||
| Change in fair value of debt due to change in credit risk | |||||
| Comprehensive loss | |||||
| Deemed dividend relating to inducement of Dragasac warrants | |||||
| Paid-in kind preferred stock dividend | |||||
| Net loss attributable to common shareholders | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average shares outstanding - basic | |||||
| Weighted average shares outstanding - diluted | |||||
Loading...